ARTICLE | Company News
Arriva, Genzyme Transgenics, Aventis S.A, Baxter Healthcare Corp., Bayer autoimmune/inflammation, dermatology news
April 9, 2001 7:00 AM UTC
Arriva and partner BAX said that following oppositions filed by AVE, BAYG and GZTC, the European Patent Office upheld, in amended form, Arriva's European Patent No. 0512090. As amended, Arriva said th...